ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
89.28 EUR
+1 (+1.13%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- In the past year ABL was profitable.
- ABL had a positive operating cash flow in the past year.
- In the past 5 years ABL has always been profitable.
- Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 7.52%, ABL belongs to the best of the industry, outperforming 85.25% of the companies in the same industry.
- The Return On Equity of ABL (12.51%) is better than 80.33% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 9.17%, ABL is in the better half of the industry, outperforming 75.41% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 10.18%.
- The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- With an excellent Profit Margin value of 14.72%, ABL belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- ABL has a Operating Margin of 18.85%. This is in the better half of the industry: ABL outperforms 78.69% of its industry peers.
- ABL's Operating Margin has improved in the last couple of years.
- ABL has a Gross Margin (56.68%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABL is destroying value.
- Compared to 1 year ago, ABL has more shares outstanding
- ABL has less shares outstanding than it did 5 years ago.
- ABL has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.82 indicates that ABL is not in any danger for bankruptcy at the moment.
- ABL's Altman-Z score of 4.82 is amongst the best of the industry. ABL outperforms 81.97% of its industry peers.
- The Debt to FCF ratio of ABL is 1.75, which is an excellent value as it means it would take ABL, only 1.75 years of fcf income to pay off all of its debts.
- ABL's Debt to FCF ratio of 1.75 is amongst the best of the industry. ABL outperforms 81.97% of its industry peers.
- A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
- ABL has a Debt to Equity ratio of 0.19. This is in the better half of the industry: ABL outperforms 72.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.82 |
ROIC/WACC0.89
WACC10.29%
2.3 Liquidity
- ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Current ratio (1.58) which is comparable to the rest of the industry.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.18, ABL is in line with its industry, outperforming 54.10% of the companies in the same industry.
- The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 10.28% over the past year.
- The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
- The Revenue has been growing slightly by 5.67% in the past year.
- The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
- ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 19.93, which indicates a rather expensive current valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued a bit cheaper than 75.41% of the companies in the same industry.
- ABL is valuated rather cheaply when we compare the Price/Earnings ratio to 25.58, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 17.87, ABL is valued on the expensive side.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (22.81), we can say ABL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.93 | ||
| Fwd PE | 17.87 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA is on the same level as the industry average.
- ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 68.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.12 | ||
| EV/EBITDA | 15.69 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.73
PEG (5Y)2.8
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABL.DE Dividend Analysis
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.41%.
- ABL's Dividend Yield is a higher than the industry average which is at 1.14.
- ABL's Dividend Yield is a higher than the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of ABL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (4/1/2026, 5:28:32 PM)
89.28
+1 (+1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap155.14B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.26 (27.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.93 | ||
| Fwd PE | 17.87 | ||
| P/S | 4.02 | ||
| P/FCF | 24.12 | ||
| P/OCF | 18.65 | ||
| P/B | 3.42 | ||
| P/tB | 7.9 | ||
| EV/EBITDA | 15.69 |
EPS(TTM)4.48
EY5.02%
EPS(NY)5
Fwd EY5.6%
FCF(TTM)3.7
FCFY4.15%
OCF(TTM)4.79
OCFY5.36%
SpS22.19
BVpS26.09
TBVpS11.3
PEG (NY)1.73
PEG (5Y)2.8
Graham Number51.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.82 |
F-Score6
WACC10.29%
ROIC/WACC0.89
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.